Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Element Biosciences develops genomic sequencing and multiomics technologies used in drug discovery, and diagnostic applications.
Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.
Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Contraline is a clinical-stage biotechnology company that develops male contraceptive solutions.
Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.
Moderna Therapeutics is a biotechnology company that develops medicines and vaccines based on messenger RNA (mRNA) technology.
Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.
Secretome Therapeutics is a clinical-stage cell therapy company that develops therapies for rare cardiac diseases.
cAMPfield Therapeutics is a biotechnology company that specializes on exploration and development activities of therapeutic solutions.
Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.
Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients.
Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.
Avalo Therapeutics is a clinical-stage biopharmaceutical company.
Windward Bio develops monoclonal antibodies for advanced immunological diseases.
GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.
Climb Bio occurs when the immune system mistakenly attacks the body's tissues and can result in permanent organ damage or even death.
Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.
Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.
Adcendo is a biotech company that develops antibody-drug conjugates (ADCs) to target cancers with high unmet medical needs.
Incyclix Bio develops small molecule inhibitors of CDKs for the treatment of advanced and resistant cancers.
Stipple Bio is a biotechnology company that offers cellular profiling and target discovery with epitope resolution.
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
RA Capital Management has invested in 467 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
RA Capital Management's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 15 different industry categories.
Among tracked funding rounds, Apogee Therapeutics received $1.3B in a Post-IPO Debt round. RA Capital Management's total known invested capital is $56.7B.
RA Capital Management's average investment size is $123.5M across its portfolio of 467 companies.
Recent RA Capital Management portfolio additions include Element Biosciences, Celcuity, Jade Biosciences, Mineralys Therapeutics, Contraline. These companies were founded in 2020 or later.